APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Reliever (Rescue) Medications

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Asthma Reliever (Rescue) Medications Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchAsthma Reliever (Rescue) Medications Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Reliever (Rescue) Medications Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Asthma Reliever (Rescue) Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Reliever (Rescue) Medications Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Reliever (Rescue) Medications Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Asthma Reliever (Rescue) Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Reliever (Rescue) Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Asthma Reliever (Rescue) Medications market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Asthma Reliever (Rescue) Medications market include AstraZeneca plc, Dulera, Genentech Inc, Glaxosmithkline plc, MAP Pharmaceuticals，Inc, Merck & Co. Inc, QVAR, Roche Holdings Ltd and Sanofi-Aventis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Reliever (Rescue) Medications market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Reliever (Rescue) Medications and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Reliever (Rescue) Medications sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Reliever (Rescue) Medications market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Reliever (Rescue) Medications Segment by Company

AstraZeneca plc

Dulera

Genentech Inc

Glaxosmithkline plc

MAP Pharmaceuticals，Inc

Merck & Co. Inc

QVAR

Roche Holdings Ltd

Sanofi-Aventis

Schering-Plough Corp

Sepracor, Inc

Theravance Inc

Asthma Reliever (Rescue) Medications Segment by Type

Quick-Relief Medications

Long-Term Control Medications

Asthma Reliever (Rescue) Medications Segment by Application

Adult

Children

Adolescent

Asthma Reliever (Rescue) Medications Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Asthma Reliever (Rescue) Medications status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Asthma Reliever (Rescue) Medications market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Asthma Reliever (Rescue) Medications significant trends, drivers, influence factors in global and regions.

6. To analyze Asthma Reliever (Rescue) Medications competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Reliever (Rescue) Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Reliever (Rescue) Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Reliever (Rescue) Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Reliever (Rescue) Medications market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Asthma Reliever (Rescue) Medications industry.

Chapter 3: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Asthma Reliever (Rescue) Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Asthma Reliever (Rescue) Medications in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Asthma Reliever (Rescue) Medications Industry Trends Table 2. Asthma Reliever (Rescue) Medications Industry Drivers Table 3. Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges Table 4. Asthma Reliever (Rescue) Medications Industry Restraints Table 5. Global Asthma Reliever (Rescue) Medications Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Asthma Reliever (Rescue) Medications Revenue Share by Company (2021-2026) Table 7. Global Asthma Reliever (Rescue) Medications Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Company (2021-2026) Table 9. Global Asthma Reliever (Rescue) Medications Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Asthma Reliever (Rescue) Medications Company Ranking, (2024-2026) & (USD Million) Table 11. Global Asthma Reliever (Rescue) Medications Key Company Manufacturing Base & Headquarters Table 12. Global Asthma Reliever (Rescue) Medications Company, Product Type & Application Table 13. Global Asthma Reliever (Rescue) Medications Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Reliever (Rescue) Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Quick-Relief Medications Table 18. Significant Companies of Long-Term Control Medications Table 19. Global Asthma Reliever (Rescue) Medications Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Asthma Reliever (Rescue) Medications Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Asthma Reliever (Rescue) Medications Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Type (2021-2026) Table 23. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Type (2027-2032) Table 24. Global Asthma Reliever (Rescue) Medications Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Asthma Reliever (Rescue) Medications Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Asthma Reliever (Rescue) Medications Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Asthma Reliever (Rescue) Medications Sales Value Share by Type (2021-2026) Table 28. Global Asthma Reliever (Rescue) Medications Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Table 30. Significant Companies of Children Table 31. Significant Companies of Adolescent Table 32. Global Asthma Reliever (Rescue) Medications Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Asthma Reliever (Rescue) Medications Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Asthma Reliever (Rescue) Medications Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Application (2021-2026) Table 36. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Application (2027-2032) Table 37. Global Asthma Reliever (Rescue) Medications Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Asthma Reliever (Rescue) Medications Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Asthma Reliever (Rescue) Medications Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Asthma Reliever (Rescue) Medications Sales Value Share by Application (2021-2026) Table 41. Global Asthma Reliever (Rescue) Medications Sales Value Share by Application (2027-2032) Table 42. Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2026) & (K Units) Table 44. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2021-2026) Table 45. Global Asthma Reliever (Rescue) Medications Sales by Region (2027-2032) & (K Units) Table 46. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2027-2032) Table 47. Global Asthma Reliever (Rescue) Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Asthma Reliever (Rescue) Medications Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Asthma Reliever (Rescue) Medications Sales Value Share by Region (2021-2026) Table 50. Global Asthma Reliever (Rescue) Medications Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Asthma Reliever (Rescue) Medications Sales Value Share by Region (2027-2032) Table 52. Global Asthma Reliever (Rescue) Medications Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Asthma Reliever (Rescue) Medications Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Asthma Reliever (Rescue) Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Asthma Reliever (Rescue) Medications Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Asthma Reliever (Rescue) Medications Sales by Country (2021-2026) & (K Units) Table 57. Global Asthma Reliever (Rescue) Medications Sales Market Share by Country (2021-2026) Table 58. Global Asthma Reliever (Rescue) Medications Sales by Country (2027-2032) & (K Units) Table 59. Global Asthma Reliever (Rescue) Medications Sales Market Share by Country (2027-2032) Table 60. Global Asthma Reliever (Rescue) Medications Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Asthma Reliever (Rescue) Medications Sales Value Market Share by Country (2021-2026) Table 62. Global Asthma Reliever (Rescue) Medications Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Asthma Reliever (Rescue) Medications Sales Value Market Share by Country (2027-2032) Table 64. AstraZeneca plc Company Information Table 65. AstraZeneca plc Business Overview Table 66. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio Table 68. AstraZeneca plc Recent Development Table 69. Dulera Company Information Table 70. Dulera Business Overview Table 71. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Dulera Asthma Reliever (Rescue) Medications Product Portfolio Table 73. Dulera Recent Development Table 74. Genentech Inc Company Information Table 75. Genentech Inc Business Overview Table 76. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 78. Genentech Inc Recent Development Table 79. Glaxosmithkline plc Company Information Table 80. Glaxosmithkline plc Business Overview Table 81. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio Table 83. Glaxosmithkline plc Recent Development Table 84. MAP Pharmaceuticals，Inc Company Information Table 85. MAP Pharmaceuticals，Inc Business Overview Table 86. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 88. MAP Pharmaceuticals，Inc Recent Development Table 89. Merck & Co. Inc Company Information Table 90. Merck & Co. Inc Business Overview Table 91. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 93. Merck & Co. Inc Recent Development Table 94. QVAR Company Information Table 95. QVAR Business Overview Table 96. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. QVAR Asthma Reliever (Rescue) Medications Product Portfolio Table 98. QVAR Recent Development Table 99. Roche Holdings Ltd Company Information Table 100. Roche Holdings Ltd Business Overview Table 101. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio Table 103. Roche Holdings Ltd Recent Development Table 104. Sanofi-Aventis Company Information Table 105. Sanofi-Aventis Business Overview Table 106. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio Table 108. Sanofi-Aventis Recent Development Table 109. Schering-Plough Corp Company Information Table 110. Schering-Plough Corp Business Overview Table 111. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio Table 113. Schering-Plough Corp Recent Development Table 114. Sepracor, Inc Company Information Table 115. Sepracor, Inc Business Overview Table 116. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 118. Sepracor, Inc Recent Development Table 119. Theravance Inc Company Information Table 120. Theravance Inc Business Overview Table 121. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio Table 123. Theravance Inc Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Asthma Reliever (Rescue) Medications Distributors List Table 127. Asthma Reliever (Rescue) Medications Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Asthma Reliever (Rescue) Medications Product Image Figure 2. Global Asthma Reliever (Rescue) Medications Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 4. Global Asthma Reliever (Rescue) Medications Sales (2021-2032) & (K Units) Figure 5. Global Asthma Reliever (Rescue) Medications Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Asthma Reliever (Rescue) Medications Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Quick-Relief Medications Image Figure 10. Long-Term Control Medications Image Figure 11. Global Asthma Reliever (Rescue) Medications Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Asthma Reliever (Rescue) Medications Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Type (2021-2032) Figure 14. Global Asthma Reliever (Rescue) Medications Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Asthma Reliever (Rescue) Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Asthma Reliever (Rescue) Medications Sales Value Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Children Image Figure 19. Adolescent Image Figure 20. Global Asthma Reliever (Rescue) Medications Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Asthma Reliever (Rescue) Medications Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Asthma Reliever (Rescue) Medications Sales Volume Share by Application (2021-2032) Figure 23. Global Asthma Reliever (Rescue) Medications Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Asthma Reliever (Rescue) Medications Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Asthma Reliever (Rescue) Medications Sales Value Share by Application (2021-2032) Figure 26. Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Asthma Reliever (Rescue) Medications Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Asthma Reliever (Rescue) Medications Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 31. North America Asthma Reliever (Rescue) Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Asthma Reliever (Rescue) Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Asthma Reliever (Rescue) Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 37. South America Asthma Reliever (Rescue) Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Asthma Reliever (Rescue) Medications Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Asthma Reliever (Rescue) Medications Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-Relief Medications
  • Long-Term Control Medications
Applications
  • Adult
  • Children
  • Adolescent
Companies covered
  • AstraZeneca plc
  • Dulera
  • Genentech Inc
  • Glaxosmithkline plc
  • MAP Pharmaceuticals，Inc
  • Merck & Co. Inc
  • QVAR
  • Roche Holdings Ltd
  • Sanofi-Aventis
  • Schering-Plough Corp
  • Sepracor, Inc
  • Theravance Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  4. 1.2.2 Global Asthma Reliever (Rescue) Medications Sales Volume (2021-2032)
  5. 1.2.3 Global Asthma Reliever (Rescue) Medications Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Asthma Reliever (Rescue) Medications Market Dynamics
  1. 2.1 Asthma Reliever (Rescue) Medications Industry Trends
  2. 2.2 Asthma Reliever (Rescue) Medications Industry Drivers
  3. 2.3 Asthma Reliever (Rescue) Medications Industry Opportunities and Challenges
  4. 2.4 Asthma Reliever (Rescue) Medications Industry Restraints
3 Asthma Reliever (Rescue) Medications Market by Company
  1. 3.1 Global Asthma Reliever (Rescue) Medications Company Revenue Ranking in 2025
  2. 3.2 Global Asthma Reliever (Rescue) Medications Revenue by Company (2021-2026)
  3. 3.3 Global Asthma Reliever (Rescue) Medications Sales Volume by Company (2021-2026)
  4. 3.4 Global Asthma Reliever (Rescue) Medications Average Price by Company (2021-2026)
  5. 3.5 Global Asthma Reliever (Rescue) Medications Company Ranking (2024-2026)
  6. 3.6 Global Asthma Reliever (Rescue) Medications Company Manufacturing Base and Headquarters
  7. 3.7 Global Asthma Reliever (Rescue) Medications Company Product Type and Application
  8. 3.8 Global Asthma Reliever (Rescue) Medications Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Asthma Reliever (Rescue) Medications Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Asthma Reliever (Rescue) Medications Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Asthma Reliever (Rescue) Medications Market by Type
  1. 4.1 Asthma Reliever (Rescue) Medications Type Introduction
  2. 4.1.1 Quick-Relief Medications
  3. 4.1.2 Long-Term Control Medications
  4. 4.2 Global Asthma Reliever (Rescue) Medications Sales Volume by Type
  5. 4.2.1 Global Asthma Reliever (Rescue) Medications Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Reliever (Rescue) Medications Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Asthma Reliever (Rescue) Medications Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Asthma Reliever (Rescue) Medications Sales Value by Type
  9. 4.3.1 Global Asthma Reliever (Rescue) Medications Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Reliever (Rescue) Medications Sales Value by Type (2021-2032)
  11. 4.3.3 Global Asthma Reliever (Rescue) Medications Sales Value Share by Type (2021-2032)
5 Asthma Reliever (Rescue) Medications Market by Application
  1. 5.1 Asthma Reliever (Rescue) Medications Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.1.3 Adolescent
  5. 5.2 Global Asthma Reliever (Rescue) Medications Sales Volume by Application
  6. 5.2.1 Global Asthma Reliever (Rescue) Medications Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Asthma Reliever (Rescue) Medications Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Asthma Reliever (Rescue) Medications Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Asthma Reliever (Rescue) Medications Sales Value by Application
  10. 5.3.1 Global Asthma Reliever (Rescue) Medications Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Asthma Reliever (Rescue) Medications Sales Value by Application (2021-2032)
  12. 5.3.3 Global Asthma Reliever (Rescue) Medications Sales Value Share by Application (2021-2032)
6 Asthma Reliever (Rescue) Medications Regional Sales and Value Analysis
  1. 6.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Reliever (Rescue) Medications Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2021-2026
  4. 6.2.2 Global Asthma Reliever (Rescue) Medications Sales by Region (2027-2032)
  5. 6.3 Global Asthma Reliever (Rescue) Medications Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Asthma Reliever (Rescue) Medications Sales Value by Region (2021-2032)
  7. 6.4.1 Global Asthma Reliever (Rescue) Medications Sales Value by Region: 2021-2026
  8. 6.4.2 Global Asthma Reliever (Rescue) Medications Sales Value by Region (2027-2032)
  9. 6.5 Global Asthma Reliever (Rescue) Medications Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  12. 6.6.2 North America Asthma Reliever (Rescue) Medications Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  15. 6.7.2 Europe Asthma Reliever (Rescue) Medications Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Asthma Reliever (Rescue) Medications Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  21. 6.9.2 South America Asthma Reliever (Rescue) Medications Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Asthma Reliever (Rescue) Medications Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Asthma Reliever (Rescue) Medications Sales Value Share by Country, 2025 VS 2032
7 Asthma Reliever (Rescue) Medications Country-level Sales and Value Analysis
  1. 7.1 Global Asthma Reliever (Rescue) Medications Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Asthma Reliever (Rescue) Medications Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Asthma Reliever (Rescue) Medications Sales by Country (2021-2032)
  4. 7.3.1 Global Asthma Reliever (Rescue) Medications Sales by Country (2021-2026)
  5. 7.3.2 Global Asthma Reliever (Rescue) Medications Sales by Country (2027-2032)
  6. 7.4 Global Asthma Reliever (Rescue) Medications Sales Value by Country (2021-2032)
  7. 7.4.1 Global Asthma Reliever (Rescue) Medications Sales Value by Country (2021-2026)
  8. 7.4.2 Global Asthma Reliever (Rescue) Medications Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Asthma Reliever (Rescue) Medications Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Asthma Reliever (Rescue) Medications Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Asthma Reliever (Rescue) Medications Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca plc
  2. 8.1.1 AstraZeneca plc Company Information
  3. 8.1.2 AstraZeneca plc Business Overview
  4. 8.1.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
  6. 8.1.5 AstraZeneca plc Recent Developments
  7. 8.2 Dulera
  8. 8.2.1 Dulera Company Information
  9. 8.2.2 Dulera Business Overview
  10. 8.2.3 Dulera Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
  12. 8.2.5 Dulera Recent Developments
  13. 8.3 Genentech Inc
  14. 8.3.1 Genentech Inc Company Information
  15. 8.3.2 Genentech Inc Business Overview
  16. 8.3.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
  18. 8.3.5 Genentech Inc Recent Developments
  19. 8.4 Glaxosmithkline plc
  20. 8.4.1 Glaxosmithkline plc Company Information
  21. 8.4.2 Glaxosmithkline plc Business Overview
  22. 8.4.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
  24. 8.4.5 Glaxosmithkline plc Recent Developments
  25. 8.5 MAP Pharmaceuticals，Inc
  26. 8.5.1 MAP Pharmaceuticals，Inc Company Information
  27. 8.5.2 MAP Pharmaceuticals，Inc Business Overview
  28. 8.5.3 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MAP Pharmaceuticals，Inc Asthma Reliever (Rescue) Medications Product Portfolio
  30. 8.5.5 MAP Pharmaceuticals，Inc Recent Developments
  31. 8.6 Merck & Co. Inc
  32. 8.6.1 Merck & Co. Inc Company Information
  33. 8.6.2 Merck & Co. Inc Business Overview
  34. 8.6.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
  36. 8.6.5 Merck & Co. Inc Recent Developments
  37. 8.7 QVAR
  38. 8.7.1 QVAR Company Information
  39. 8.7.2 QVAR Business Overview
  40. 8.7.3 QVAR Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
  42. 8.7.5 QVAR Recent Developments
  43. 8.8 Roche Holdings Ltd
  44. 8.8.1 Roche Holdings Ltd Company Information
  45. 8.8.2 Roche Holdings Ltd Business Overview
  46. 8.8.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
  48. 8.8.5 Roche Holdings Ltd Recent Developments
  49. 8.9 Sanofi-Aventis
  50. 8.9.1 Sanofi-Aventis Company Information
  51. 8.9.2 Sanofi-Aventis Business Overview
  52. 8.9.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
  54. 8.9.5 Sanofi-Aventis Recent Developments
  55. 8.10 Schering-Plough Corp
  56. 8.10.1 Schering-Plough Corp Company Information
  57. 8.10.2 Schering-Plough Corp Business Overview
  58. 8.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
  60. 8.10.5 Schering-Plough Corp Recent Developments
  61. 8.11 Sepracor, Inc
  62. 8.11.1 Sepracor, Inc Company Information
  63. 8.11.2 Sepracor, Inc Business Overview
  64. 8.11.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
  66. 8.11.5 Sepracor, Inc Recent Developments
  67. 8.12 Theravance Inc
  68. 8.12.1 Theravance Inc Company Information
  69. 8.12.2 Theravance Inc Business Overview
  70. 8.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
  72. 8.12.5 Theravance Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Reliever (Rescue) Medications Value Chain Analysis
  2. 9.1.1 Asthma Reliever (Rescue) Medications Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Reliever (Rescue) Medications Sales Mode & Process
  6. 9.2 Asthma Reliever (Rescue) Medications Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Reliever (Rescue) Medications Distributors
  9. 9.2.3 Asthma Reliever (Rescue) Medications Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst